Bringing Life to Those Near Death

NCT05466123 | Enrolling By Invitation

• 1 other identifier: 21-007346
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to assess whether virtual reality technology can reduce anxiety, depression, and emotional distress screening scores in palliative care patients.

Conditions

Palliative Care

Outcome Measures

Primary Outcomes (2)

• Change in anxiety

  Measured using the self-reported Generalized Anxiety Disorder-7 (GAD-7) questionnaire. Subjects rank how often they have been bother by specific problems within the last 2 weeks on a scale of 0 being not at all and 3 being nearly every day. Total scores range from 0-20, with higher scores indicating more anxiety severity.

  Baseline, post-intervention approximately 30 minutes

• Change in emotional distress

  Measured using the self-reported Distress from Death and Dying Survey. Subjects rank their distress on a scale or 0-10, 0 being no distress at all, and 10 being completely distressed. Total scores range from 0-130, with higher scores indicating more distress severity.

  Baseline, post-intervention approximately 30 minutes

Study Arms (1)

Virtual reality intervention in palliative care patients

EXPERIMENTAL

Palliative care patients with a limited life expectancy will participate in a virtual reality experience for 10-30 minutes

Behavioral: Virtual Reality

Interventions

Virtual Reality BEHAVIORAL

Simulated travel destination or activity of the participants choosing that would otherwise be inaccessible

Virtual reality intervention in palliative care patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• A terminal or end-stage condition with an expected prognosis of a year or less.
• An established palliative care patient.
• English-speaking.
• Able to wear virtual reality equipment (goggles, etc.).
• Subject or Caregiver able to provide consent.

You may not qualify if:

• Younger than 18 years of age.
• Lack of a prognosis of approximately 1 year or less.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic Florida

Jacksonville, Florida, 32224, United States

Location

Study Officials

• Chimere Bruning, PA-C

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 15, 2022
• First Posted: July 20, 2022
• Study Start: November 9, 2023
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: January 16, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)